Current Affairs - National - Discussion

The Council of Scientific and Industrial Research (CSIR) has started the trial of Mycobacterium w (Mw), an anti-leprosy drug. The information was passed by the Director of CSIR Shekhar Mande. Under this one particular formulation, called "Mycobacterium w (Mw)", a heat-killed bacteria will be tried on different COVID-19 patients. CSIR has been granted approval to conduct the trial from the Drug Controller General of India (DCGI).